Franklin R. Cockerill, III, MD

Diagnostics, Companion Diagnostics, Population Health, Digital Health

Bio

Dr. Cockerill has been a leader in development and commercialization of diagnostics and medical services across disease areas and technologies. He most recently served as the CEO and CMO of Analyte Health, a leader in virtual care diagnostic services. Before joining Analyte Health, Dr. Cockerill was the Chair of the Department of Laboratory Medicine and Pathology, Mayo Clinic, and President and CEO of Mayo Medical Laboratories. While at Mayo he also carried a named professorship, the Ann and Leo Markin Professor of Medicine and Microbiology at the Mayo Medical School.

Dr. Cockerill and his research team at Mayo developed numerous real-time PCR assays, which have significant advantages over conventional culture-based assays, and include the first commercially available rapid PCR test for Anthrax. This work has resulted in 10 patents and 56 licensed technologies. Recently, Dr. Cockerill provided a pivotal role for one of the first clinical studies of self-swabbing for COVID-19 infection in the US. He helped coordinate the swift development and execution of the study, along with the Gates Foundation, Everett Clinic (United Healthcare) and Quest Diagnostics, in March 2020 which resulted in one of the earliest FDA emergency use self-testing methods for COVID-19.

Expertise

Dr. Cockerill is Board Certified in Internal Medicine, Infectious Diseases and Clinical Microbiology. He has served as Chair of the Subcommittee on Antimicrobial Susceptibility Testing, Clinical Laboratory Standards Institute (CLSI), Chair, Microbiology Devices Panel of the Medical Devices Advisory Committee of the US FDA, Board Member and Program Director, of the Association for Molecular Pathology (AMP), Director, American Clinical Laboratory Association Board; Director, Board of Scientific Counselors of the Centers for Disease Control and Prevention (CDC) and Editor, Journal of Clinical Microbiology. Dr. Cockerill was the recipient of the BD Award, sponsored by the American Society for Microbiology (ASM), the highest honor bestowed upon a clinical microbiologist in the United States.

Go to Top